This trial investigates whether a natural product derived from hops is safe and tolerable for people with Crohn's Disease, and whether it produces a biological signature in these patients.
6 Primary · 3 Secondary · Reporting Duration: 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Experimental Treatment
Non-Treatment Group
32 Total Participants · 2 Treatment Groups
Primary Treatment: Xanthohumol · Has Placebo Group · Phase 2
Age 21 - 50 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: